Advertisement
Lipocine Says FDA Oks LPCN 2101 IND For Adult Epilepsy Treatment
(RTTNews) - Biopharmaceutical company Lipocine Inc. (LPCN) announced Monday that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug Application (IND) for its neuroactive steroid (NAS) candidate, LPCN 2101, as a potential treatment for adults with epilepsy.
Lipocine plans to initiate a Phase 2 photosensitive epilepsy (PSE) study to evaluate the safety, tolerability, and efficacy of oral LPCN 2101.
LPCN 2101 is an orally delivered, endogenous neuroactive steroid (NAS), a positive allosteric modulator (PAM) of GABAA receptor, with potential therapeutic effects in neurological and mood disorders.
For More Such Health News, visit rttnews.com
read more
Taiwan Stock Market Expected To Open In The Green
The Taiwan stock market has moved higher in four straight sessions, rallying more than 700 points or 3 percent along the way. The Taiwan Stock Exchange now sits just beneath the 24,160-point plateau and it may see additional support again on Wednesday.
RTTNews
|
vor 14 Minuten
Singapore Shares May Stop The Bleeding On Wednesday
The Singapore stock market has finished lower in three straight sessions, slipping almost 40 points or 0.9 percent along the way. The Straits Times Index now sits just above the 4,220-point plateau although it may find traction on Wednesday.
RTTNews
|
vor 44 Minuten
Japan Producer Prices Rise 0.2% In July
Producer prices in Japan were up 0.2 percent on month in July, the Bank of Japan said on Wednesday.
RTTNews
|
vor 47 Minuten
Win Streak May Continue For Malaysia Stock Market
The Malaysia stock market has moved higher in six straight sessions, collecting more than 40 points or 2.7 percent along the way. The Kuala Lumpur Composite Index now sits just above the 1,565-point plateau and it's tipped to open in the green again on Wednesday.
RTTNews
|
vor 1Std 14 Minuten
Overbought Japan Bourse Nonetheless Called Higher On Wednesday
The Japan stock market had moved higher in five consecutive sessions, advancing more than 2,480 points or 6 percent along the way. The Nikkei 225 now sits just beneath the 42,720-point plateau and it has a positive lead again on Wednesday.
RTTNews
|
vor 1Std 29 Minuten
KOSPI Poised To Halt Losing Streak
The South Korea stock market has finished lower in three straight sessions, sinking more than 35 points or 1.2 percent along the way. The KOSPI now sits just beneath the 3,190-point plateau although it may stop the bleeding on Wednesday.
RTTNews
|
vor 1Std 44 Minuten
Australia Wage Price Data Due On Wednesday
Australia will on Wednesday release Q2 data for its wage price index, highlighting a modest day for Asia-Pacific economic activity. Wages are expected to rise 0.8 percent on quarter and 3.3 percent on year, easing from 0.9 percent on quarter and 34 percent on year in the three months prior.
RTTNews
|
vor 2Std 44 Minuten
U.S. Dollar Falls Against Majors
The U.S. dollar dropped against its major counterparts in the New York session on Tuesday.
RTTNews
|
vor 3Std 41 Minuten
